Abstract
Nominal effect concentrations from in vitro toxicity assays may lead to inaccurate estimations of in vivo toxic doses because the nominal concentration poorly reflects the concentration at the molecular target in cells in vitro, which is responsible for initiating effects and can be referred to as the biologically effective dose. Chemicals can differentially distribute between in vitro assay compartments, including serum constituents in exposure medium, microtitre plate plastic, headspace and extracellular matrices. The partitioning of test chemicals to these extracellular compartments reduces the concentration at the molecular target. Free concentrations in medium and cell-associated concentrations are considered better proxies of the biologically effective dose. This paper reviews the mechanisms by which test chemicals distribute between in vitro assay compartments, and also lists the physicochemical properties driving the extent of this distribution. The mechanisms and physicochemical properties driving the distribution of test chemical in vitro help explain the makeup of mass balance models that estimate free concentrations and cell-associated concentrations in in vitro toxicity assays. A thorough understanding of the distribution processes and assumptions underlying these mass balance models helps define chemical and biological applicability domains of individual models, as well as provide a perspective on how to improve model predictivity and quantitative in vitro-in vivo extrapolations.
Original language | English |
---|---|
Article number | 105133 |
Number of pages | 20 |
Journal | Toxicology in Vitro |
Volume | 73 |
DOIs | |
Publication status | Published - Jun 2021 |
Bibliographical note
Funding Information:This review was commissioned by Cosmetics Europe as part of the IV-Kin project within its LRSS programme. We gratefully acknowledge the financial support given to the individual authors to draft the manuscript, including the Marie Sklodowska-Curie Action-Innovative Training Network-project in3, under grant no. 721975 , the CEFIC LRI ECO36 project funded by CEFIC Long-Range Research Initiative (LRI), and the EU Horizon 2020 EUToxRisk project No 681002 .
Publisher Copyright:
© 2021 The Author(s)
Keywords
- QIVIVE
- free concentration
- in vitro assays
- mass balance
- partitioning
- pharmacokinetics